Targeted IDH Mutation Sequencing
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : The Lundquist Institute
Other organizations : UCLA Health, University of California, Los Angeles
Variable analysis
- IDH1 residue 132 mutation (R132 for wild type)
- IDH2 residue 172 mutation (R172 for wild type)
- IDH2 residue 140 mutation (R140 for wild type)
- Not explicitly mentioned
- Formalin-fixed paraffin-embedded or frozen tissue samples
- Primers used for IDH1 and IDH2 sequencing
- Sanger sequencing method
- BigDye Terminator v1.1 and 3730 sequencer used for sequencing analysis
- Positive control: Wild-type IDH1 (R132) and IDH2 (R172, R140) sequences
- Negative control: Not mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!